A randomized placebo-controlled trial of adefovir dipivoxil in advanced HIV infection: the ADHOC trial.
OBJECTIVES: To assess the efficacy and safety of adefovir dipivoxil (ADV) added to stable background antiretroviral therapy (ART) in HIV-infected individuals with advanced HIV disease. METHODS: ADHOC was a randomized, double-blind, placebo-controlled, international multicentre trial. Three hundred...
Auteur principal: | ADHOC International Steering Committee |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
2002
|
Documents similaires
-
Adefovir dipivoxil induces DNA replication stress and augments ATR inhibitor-related cytotoxicity
par: Patel, A, et autres
Publié: (2020) -
Albendazole treatment of HIV-1 and helminth co-infection: a randomized, double-blind, placebo-controlled trial.
par: Walson, J, et autres
Publié: (2008) -
Moderate to severe HIV-associated neurocognitive impairment: A randomized placebo-controlled trial of lithium
par: Decloedt, E, et autres
Publié: (2016) -
What's in placebos: who knows? Analysis of randomized, controlled trials.
par: Golomb, B, et autres
Publié: (2010) -
Optimizing the design of invasive placebo interventions in randomized controlled trials
par: Cousins, S, et autres
Publié: (2020)